Immunome, Inc. (IMNM)

Immunome Revenue

Immunome had revenue of $2.91M in the quarter ending September 30, 2024, a decrease of -18.37%. This brings the company's revenue in the last twelve months to $10.13M, down -0.62% year-over-year. In the year 2023, Immunome had annual revenue of $14.02M.

• Revenue (ttm): $10.13M
• Revenue Growth: -0.62%
• P/S Ratio: 50.40
• Revenue / Employee: $184,164
• Employees: 55
• Market Cap: 778.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	14.02M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.